NCT05049447View on ClinicalTrials.gov

Pharmacological Effects of Pascoflair® on Brain Activity in Patients Suffering From Test Anxiety

PHASE4CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions

StressBrain ActivityPassiflora IncarnataTest Anxiety

Interventions

DRUG

Pascoflair

1 x 2 tablets (single-dose)

OTHER

Placebo

1 x 2 tablets (single-dose)

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

NeuroCode AG

UNKNOWN

lead

Pascoe Pharmazeutische Praeparate GmbH

INDUSTRY